Madrigal Stock Future Price Prediction


USD 70.20  1.39  2.02%   

Madrigal Pharmaceuticals stock price prediction is an act of determining the future value of Madrigal Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Madrigal Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Madrigal Pharmaceuticals and does not consider all of the tangible or intangible factors available from Madrigal Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Madrigal Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Additionally, see Madrigal Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Madrigal Pharmaceuticals based on different types of headlines from major news networks to social media. The Madrigal stock price prediction module provides an analysis of price elasticity to changes in media outlook on Madrigal Pharmaceuticals over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Using Madrigal Pharmaceuticals hype-based prediction, you can estimate the value of Madrigal Pharmaceuticals from the perspective of Madrigal Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Madrigal Pharmaceuticals using Madrigal Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Madrigal using crowd psychology based on the activity and movement of Madrigal Pharmaceuticals' stock price.
Madrigal Pharmaceuticals Revenue to Assets are relatively stable at the moment as compared to the past year. The company's current value of Revenue to Assets is estimated at 0.001684. Total Assets Per Share is expected to hike to 24.21 this year, although the value of Cash Flow Per Share will most likely fall to (11.60) .

Madrigal Pharmaceuticals Implied Volatility

Madrigal Pharmaceuticals' implied volatility exposes the market's sentiment of Madrigal Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Madrigal Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Madrigal Pharmaceuticals stock will not fluctuate a lot when Madrigal Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Madrigal Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Madrigal Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Madrigal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Madrigal Pharmaceuticals after-hype prediction price

  $ 68.83  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Madrigal contract

Based on the Rule 16, the options market is currently suggesting that Madrigal Pharmaceuticals will have an average daily up or down price movement of about 24.87% per day over the life of the 2022-12-16 option contract. With Madrigal Pharmaceuticals trading at $70.2, that is roughly $17.46. If you think that the market is fully incorporating Madrigal Pharmaceuticals' daily price movement you should consider acquiring Madrigal Pharmaceuticals options at the current volatility level of 397.91%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Madrigal Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Madrigal Pharmaceuticals in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
10 Analysts
LowTarget PriceHigh
Estimates (8)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Madrigal Pharmaceuticals. Your research has to be compared to or analyzed against Madrigal Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Madrigal Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Madrigal Pharmaceuticals.

Madrigal Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Madrigal Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Madrigal Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Madrigal Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Madrigal Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Madrigal Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Madrigal Pharmaceuticals' historical news coverage. Madrigal Pharmaceuticals' after-hype downside and upside margins for the prediction period are 64.57 and 73.09, respectively. We have considered Madrigal Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 70.20
After-hype Price
Madrigal Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Madrigal Pharmaceuticals is based on 3 months time horizon.

Madrigal Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Madrigal Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Madrigal Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Madrigal Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.03  4.32  0.05    0.18  1 Events / Month1 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Madrigal Pharmaceuticals Hype Timeline

Madrigal Pharmaceuticals is now traded for 70.20. The entity has historical hype elasticity of 0.05 and average elasticity to hype of competition of -0.18. Madrigal is forecasted to increase in value after the next headline with the price projected to jump to 68.83 or above. The average volatility of media hype impact on the company stock price is over 100%. The price surge on the next news is forecasted to be 0.03% whereas the daily expected return is now at 0.03%. The volatility of related hype on Madrigal Pharmaceuticals is about 71.21% with expected price after next announcement by competition of 70.02. The company reported the previous year's revenue of 147 K. Net Loss for the year was (255.9 M) with profit before overhead, payroll, taxes, and interest of 10.31 M. Given the investment horizon of 90 days the next forecasted press release will be very soon.
Additionally, see Madrigal Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Madrigal Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Madrigal Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Madrigal Pharmaceuticals' future price movements. Getting to know how Madrigal Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Madrigal Pharmaceuticals may potentially react to the hype associated with one of its peers.

Madrigal Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Madrigal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Madrigal using various technical indicators. When you analyze Madrigal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Madrigal Pharmaceuticals Predictive Indicators

The successful prediction of Madrigal Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Madrigal Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Madrigal Pharmaceuticals based on analysis of Madrigal Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Madrigal Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Madrigal Pharmaceuticals's related companies.
 2021 2022 (projected)
Long Term Debt to Equity0.08210.0843
Interest Coverage330.43328.5

Story Coverage note for Madrigal Pharmaceuticals

The number of cover stories for Madrigal Pharmaceuticals depends on current market conditions and Madrigal Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Madrigal Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Madrigal Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Madrigal Pharmaceuticals Short Properties

Madrigal Pharmaceuticals' future price predictability will typically decrease when Madrigal Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Madrigal Pharmaceuticals often depends not only on the future outlook of the potential Madrigal Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Madrigal Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out9.06%
Short Percent Of Float11.11%
Float Shares7.42M
Shares Short Prior Month1.49M
Average Daily Volume Last 10 Day264.6k
Average Daily Volume In Three Month267.27k
Date Short Interest14th of October 2022
Additionally, see Madrigal Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Note that the Madrigal Pharmaceuticals information on this page should be used as a complementary analysis to other Madrigal Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Madrigal Stock analysis

When running Madrigal Pharmaceuticals price analysis, check to measure Madrigal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Madrigal Pharmaceuticals is operating at the current time. Most of Madrigal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Madrigal Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Madrigal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Madrigal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Madrigal Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.1 B
Return On Assets
Return On Equity
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Madrigal Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.